In line with this, a decline in mitophagy is associated with activation of hepatic NLRP3 inflammasome in a murine mouse model of NASH and palmitic acid-treated primary hepatocytes [108], suggesting that decreased mitophagy might promote inflammation and NASH development. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.